Our products and services are used to help care for critically and chronically ill patients.
With our corporate philosophy of "caring for life", we are committed to putting essential medicines and technologies in the hands of people who help patients and to finding the best answers to the challenges they face.
Our product portfolio comprises a comprehensive range of I.V. generic drugs, infusion therapies and clinical nutrition products as well as the devices for administering these products. In the field of biosimilars, we focus on autoimmune diseases and oncology. In 2019, the first biosimilar product by Fresenius Kabi was launched. Within transfusion medicine and cell therapies, Fresenius Kabi offers products for collection of blood components and extracorporeal therapies.
Our long-standing expertise in pharmaceuticals and devices allows us to support clinical staff and care professionals as they provide the best therapy for patients. As a global healthcare company with a decentralized organization, we are ideally placed to meet the needs of our customers and patients worldwide. Every day, about 40,500 employees share one passion for "caring for life". It is our commitment to what matters most in healthcare: Improving the patients’ quality of life.